Free Fatty Acid Induces Apoptosis via Retinoic Acid Receptor-Related Orphan Receptor Alpha (RORA)-Mediated Protein Tyrosine Phosphatase Non-Receptor Type 2 (PTPN2) Downregulation in Hepatic Cells

Teja Naveen Sata; Md Ismail; Ajay Kumar Yadav; Shaivyanand Singh; Gopal Sharma; Amrendra Kumar Sah; Tannavi Sharma; Senthil Kumar Venugopal

doi:10.53941/ijctm.2025.1000026

Abstract

Background: Retinoic Acid Receptor-Related Orphan Receptor Alpha (RORA) is a transcription factor in addition to a nuclear orphan receptor. It was shown to regulate the expression of various proteins that regulate hepatic functions. RORA expression was downregulated under Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) conditions; however, there is limited data on the mechanisms by which RORA regulates MASLD. Protein Tyrosine Phosphatase Non-Receptor Type 2 (PTPN2) participates in the process of dephosphorylating various receptor and non-receptor tyrosine protein kinases, which play a significant role in the signalling of various cellular operations. PTPN2 was reported to be suppressed in obesity-associated metabolic dysfunction-associated steatohepatitis (MASH). Methods: HepG2 cells were treated with 300 µM palmitic acid (PA) for 72 h, and the expression of RORA, PTPN2, Bcl-xL (BCL2L1), BAX, and β-actin was determined using immunoblotting. Promoter analysis of PTPN2 was performed through JASPAR CORE database enrichment analysis. HepG2 cells were treated with either RORA natural agonist or synthetic antagonist, and the regulation of PTPN2 and apoptosis was studied. siRNAs targeting PTPN2 (siPTPN2) were transfected into HepG2 cells, and PTPN2 and apoptotic marker expression was assessed. Three sets of six C57BL/6 mice were given either CSAA, CDAA, or a normal diet for a total of 54 weeks. Liver tissues were separated after feeding, and immunoblotting was performed using total protein. Key Findings: RORA and PTPN2 expression were downregulated, and apoptosis was upregulated in PA-treated hepatic cells. JASPAR CORE database enrichment analysis of PTPN2 promoter analysis revealed the presence of ROR response element (RORE). PTPN2 expression was upregulated and downregulated in hepatic cells treated with RORA natural agonist and synthetic antagonist, respectively. Apoptosis was unregulated in siPTPN2-transfected hepatic cells. In CDAA diet-fed mice, RORA and PTPN2 expression were suppressed, and apoptotic markers were upregulated. Conclusions: According to the study’s findings, palmitic acid induced apoptosis by inhibiting RORA-mediated PTPN2 expression in hepatic cells. These findings can help in the development of novel therapeutic modalities using potent activators of RORA for the treatment of MASLD.

References

1.
Trefts, E.; Gannon, M.; Wasserman, D.H. The Liver. Curr. Biol. 2017, 27, R1147–R1151. https://doi.org/10.1016/j.cub.2017.09.019.
2.
Kalra, A.; Yetiskul, E.; Wehrle, C.J.; et al. Physiology, Liver. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2025.
3.
Hardy, T.; Oakley, F.; Anstee, Q.M.; et al. Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum. Annu. Rev. Pathol. 2016, 11, 451–496. https://doi.org/10.1146/annurev-pathol-012615-044224.
4.
Sabini, J.H.; Timotius, K.H. Hepatoprotective and Fat-Accumulation-Reductive Effects of Curcumin on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Curr. Issues Mol. Biol. 2025, 47, 159. https://doi.org/10.3390/cimb47030159.
5.
Vitale, I.; Pietrocola, F.; Guilbaud, E.; et al. Apoptotic Cell Death in Disease—Current Understanding of the NCCD 2023. Cell Death Differ. 2023, 30, 1097–1154. https://doi.org/10.1038/s41418-023-01153-w.
6.
de Almeida, I.T.; Cortez-Pinto, H.; Fidalgo, G.; et al. Plasma Total and Free Fatty Acids Composition in Human Non-Alcoholic Steatohepatitis. Clin. Nutr. 2002, 21, 219–223. https://doi.org/10.1054/clnu.2001.0529.
7.
Ogawa, Y.; Imajo, K.; Honda, Y.; et al. Palmitate-Induced Lipotoxicity Is Crucial for the Pathogenesis of Nonalcoholic Fatty Liver Disease in Cooperation with Gut-Derived Endotoxin. Sci. Rep. 2018, 8, 11365. https://doi.org/10.1038/s41598-018-29735-6.
8.
Cazanave, S.C.; Mott, J.L.; Elmi, N.A.; et al. JNK1-Dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis. J. Biol. Chem. 2009, 284, 26591–26602. https://doi.org/10.1074/jbc.M109.022491.
9.
Yang, X.; Gonzalez, F.J.; Huang, M.; et al. Nuclear Receptors and Non-Alcoholic Fatty Liver Disease: An Update. Liver Res. 2020, 4, 88–93. https://doi.org/10.1016/j.livres.2020.03.001.
10.
Chai, C.; Cox, B.; Yaish, D.; et al. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-Regulation of MicroRNA 122. Gastroenterology 2020, 159, 999–1014.e9. https://doi.org/10.1053/j.gastro.2020.05.056.
11.
Han, Y.-H.; Kim, H.-J.; Lee, M.-O. RORα Regulates Hepatic Lipolysis by Inducing Transcriptional Expression of PNPLA3 in Mice. Mol. Cell. Endocrinol. 2021, 522, 111122. https://doi.org/10.1016/j.mce.2020.111122.
12.
Han, Y.-H.; Kim, H.-J.; Na, H.; et al. RORα Induces KLF4-Mediated M2 Polarization in the Liver Macrophages That Protect against Nonalcoholic Steatohepatitis. Cell Rep. 2017, 20, 124–135. https://doi.org/10.1016/j.celrep.2017.06.017.
13.
Han, Y.-H.; Kim, H.-J.; Kim, E.-J.; et al. RORα Decreases Oxidative Stress through the Induction of SOD2 and GPx1 Expression and Thereby Protects against Nonalcoholic Steatohepatitis in Mice. Antioxid. Redox Signal. 2014, 21, 2083–2094. https://doi.org/10.1089/ars.2013.5655.
14.
Wang, D.; Wang, W.; Song, M.; et al. Regulation of Protein Phosphorylation by PTPN2 and Its Small-Molecule Inhibitors/Degraders as a Potential Disease Treatment Strategy. Eur. J. Med. Chem. 2024, 277, 116774. https://doi.org/10.1016/j.ejmech.2024.116774.
15.
Grohmann, M.; Wiede, F.; Dodd, G.T.; et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell 2018, 175, 1289–1306.e20. https://doi.org/10.1016/j.cell.2018.09.053.
16.
Matsumoto, M.; Hada, N.; Sakamaki, Y.; et al. An Improved Mouse Model That Rapidly Develops Fibrosis in Non-Alcoholic Steatohepatitis. Int. J. Exp. Pathol. 2013, 94, 93–103. https://doi.org/10.1111/iep.12008.
17.
Gearing, L.J.; Cumming, H.E.; Chapman, R.; et al. CiiiDER: A Tool for Predicting and Analysing Transcription Factor Binding Sites. PLoS ONE 2019, 14, e0215495. https://doi.org/10.1371/journal.pone.0215495.
18.
Byun, J.-K.; Choi, Y.-K.; Kang, Y.N.; et al. Retinoic Acid-Related Orphan Receptor Alpha Reprograms Glucose Metabolism in Glutamine-Deficient Hepatoma Cells. Hepatology 2015, 61, 953–964. https://doi.org/10.1002/hep.27577.
19.
Kim, E.-J.; Yoon, Y.-S.; Hong, S.; et al. Retinoic Acid Receptor-Related Orphan Receptor α-Induced Activation of Adenosine Monophosphate-Activated Protein Kinase Results in Attenuation of Hepatic Steatosis. Hepatology 2012, 55, 1379–1388. https://doi.org/10.1002/hep.25529.
20.
Rinella, M.E.; Sookoian, S. From NAFLD to MASLD: Updated Naming and Diagnosis Criteria for Fatty Liver Disease. J. Lipid Res. 2023, 65, 100485. https://doi.org/10.1016/j.jlr.2023.100485.
21.
de Alwis, N.M.W.; Day, C.P. Non-Alcoholic Fatty Liver Disease: The Mist Gradually Clears. J. Hepatol. 2008, 48, S104–S112. https://doi.org/10.1016/j.jhep.2008.01.009.
22.
Boonkaew, B.; Satthawiwat, N.; Pachane, B.C.; et al. Palmitic Acid Reduces LDLR-Dependent Uptake of Macrophage-Derived Extracellular Vesicles by Hepatoma Cells. Non-Coding RNA Res. 2025, 13, 71–83. https://doi.org/10.1016/j.ncrna.2025.04.007.
23.
Yadav, A.K.; Sata, T.N.; Verma, D.; et al. Free Fatty Acid-Induced miR-181a-5p Stimulates Apoptosis by Targeting XIAP and Bcl2 in Hepatic Cells. Life Sci. 2022, 301, 120625. https://doi.org/10.1016/j.lfs.2022.120625.
24.
Tang, C.; Feng, W.; Bao, Y.; et al. Long Non-Coding RNA TINCR Promotes Hepatocellular Carcinoma Proliferation and Invasion via STAT3 Signaling by Direct Interacting with T-Cell Protein Tyrosine Phosphatase (TCPTP). Bioengineered 2021, 12, 2119–2131. https://doi.org/10.1080/21655979.2021.1930336.
25.
Moore, F.; Colli, M.L.; Cnop, M.; et al. PTPN2, a Candidate Gene for Type 1 Diabetes, Modulates Interferon-γ–Induced Pancreatic β-Cell Apoptosis. Diabetes 2009, 58, 1283–1291. https://doi.org/10.2337/db08-1510.
26.
Laudet, V.; Hänni, C.; Coll, J.; et al. Evolution of the Nuclear Receptor Gene Superfamily. EMBO J. 1992, 11, 1003–1013.
27.
Lin, S.-J.; Yang, D.-R.; Yang, G.; et al. Chapter Thirteen—TR2 and TR4 Orphan Nuclear Receptors: An Overview. In Current Topics in Developmental Biology; Forrest, D., Tsai, S., Eds.; Nuclear Receptors in Development and Disease; Academic Press: Cambridge, MA, USA, 2017; Volume 125, pp. 357–373.
28.
Giguère, V.; McBroom, L.D.; Flock, G. Determinants of Target Gene Specificity for ROR Alpha 1: Monomeric DNA Binding by an Orphan Nuclear Receptor. Mol. Cell. Biol. 1995, 15, 2517–2526. https://doi.org/10.1128/MCB.15.5.2517.

Scilight Press

Author Information

Abstract

Keywords

References

About Scilight

Journals

Publishing Policies

Contact Us